4ZUD
Crystal Structure of Human Angiotensin Receptor in Complex with Inverse Agonist Olmesartan at 2.8A resolution.
Experimental procedure
| Experimental method | SINGLE WAVELENGTH |
| Source type | SYNCHROTRON |
| Source details | APS BEAMLINE 23-ID-D |
| Synchrotron site | APS |
| Beamline | 23-ID-D |
| Temperature [K] | 100 |
| Detector technology | PIXEL |
| Collection date | 2014-12-31 |
| Detector | PSI PILATUS 6M |
| Wavelength(s) | 1.0330 |
| Spacegroup name | P 32 |
| Unit cell lengths | 41.200, 41.200, 251.160 |
| Unit cell angles | 90.00, 90.00, 120.00 |
Refinement procedure
| Resolution | 35.680 - 2.800 |
| R-factor | 0.19588 |
| Rwork | 0.194 |
| R-free | 0.23450 |
| Structure solution method | MOLECULAR REPLACEMENT |
| Starting model (for MR) | PDB 4YAY |
| RMSD bond length | 0.009 |
| RMSD bond angle | 1.133 |
| Data reduction software | XDS |
| Data scaling software | XSCALE |
| Phasing software | PHASER |
| Refinement software | REFMAC (5.8.0103) |
Data quality characteristics
| Overall | Outer shell | |
| Low resolution limit [Å] | 35.680 | 2.870 |
| High resolution limit [Å] | 2.800 | 2.800 |
| Rmerge | 0.054 | 0.758 |
| Number of reflections | 11028 | |
| <I/σ(I)> | 11.05 | 1.17 |
| Completeness [%] | 94.0 | 85.3 |
| Redundancy | 2.36 | 2.09 |
Crystallization Conditions
| crystal ID | method | pH | temperature | details |
| 1 | LIPIDIC CUBIC PHASE | 5 | 293 | 100 mM sodium citrate, pH 5.0, 400 mM KH2PO4, 25% (v/v) PEG400, and 6% (v/v) DMSO |
